Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer, often developing in patients with chronic liver disease or cirrhosis. At KD Hospital, under the expert care of Dr. V. Y. Bhargav, patients receive comprehensive evaluation, advanced diagnostic investigations, and customized treatment strategies to manage this complex condition effectively.
Dr. Bhargav emphasizes early detection, as HCC can progress silently and rapidly. With access to advanced imaging, endoscopy, and liver-specific diagnostics, he ensures accurate staging of the disease. At KD Hospital, treatment plans are tailored based on the stage of cancer, liver function, and overall patient health. Options include curative treatments like surgical resection and liver transplantation, as well as minimally invasive approaches such as Radiofrequency Ablation (RFA), Transarterial Chemoembolization (TACE), and targeted systemic therapies.
Patients also benefit from a multidisciplinary team approach, where hepatologists, oncologists, radiologists, and surgeons collaborate to provide holistic care. Dr. Bhargav focuses not only on treating the tumor but also on managing underlying liver disease and preventing complications.